Clinical Drug Development Data Analysis: Concepts

PMC 6212 4 Quarter Hours
Course Level Graduate
Description Examines the process of planning, collecting, analyzing, and reporting data from drug development studies. Focuses on the goals of each phase (1-4) of the clinical drug development process and how to achieve these objectives within the confines of the FDA regulations and ICH guidelines. Covers requirements in other countries, including the UK Data Protection Act, issues related to the differences between the development of drugs for oncologic or AIDS indications compared to traditional drugs, cultural influences, current standards of therapy, the need for validated tools, and failure analyses. Prereq. (a) BTC 6210 and (b) RGA 6100 or PJM 6000.

Course Sections

There are no current sections scheduled for this course.
Next Class Starts
  • Summer Term
    Jul 28, 2014 (4-week classes)
  • Fall Term
    Sep 8, 2014 (6- and 12-week classes)
    Oct 20, 2014 (6-week classes)

Academic Calendar

Talk to an Enrollment Coach

We can walk you through your program options and the application process.

 

Call Toll Free:
877.668.7727
Email:
Contact Us
©